Etanercept in graft-versus-host disease

被引:24
作者
Andolina, M [1 ]
Rabusin, M [1 ]
Maximova, N [1 ]
Di Leo, G [1 ]
机构
[1] Inst Maternal & Child Hlth, Bone Marrow Unit, Trieste, Italy
关键词
D O I
10.1038/sj.bmt.1702638
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:929 / 929
页数:1
相关论文
共 6 条
  • [1] Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
    Brown, GR
    Lindberg, G
    Meddings, J
    Silva, M
    Beutler, B
    Thiele, D
    [J]. GASTROENTEROLOGY, 1999, 116 (03) : 593 - 601
  • [2] Differential effects of anti-Fas ligand and anti-tumor necrosis factor α antibodies on acute graft-versus-host disease pathologies
    Hattori, K
    Hirano, T
    Miyajima, H
    Yamakawa, N
    Tateno, M
    Oshimi, K
    Kayagaki, N
    Yagita, H
    Okumura, K
    [J]. BLOOD, 1998, 91 (11) : 4051 - 4055
  • [3] Etanercept in children with polyarticular juvenile rheumatoid arthritis.
    Lovell, DJ
    Giannini, EH
    Reiff, A
    Cawkwell, GD
    Silverman, ED
    Nocton, JJ
    Stein, LD
    Gedalia, A
    Ilowite, NT
    Wallace, CA
    Whitmore, J
    Finck, BK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11) : 763 - 769
  • [4] MOHLER KM, 1993, J IMMUNOL, V151, P1548
  • [5] TUMOR-NECROSIS-FACTOR CACHECTIN IS AN EFFECTOR OF SKIN AND GUT LESIONS OF THE ACUTE PHASE OF GRAFT-VS-HOST DISEASE
    PIGUET, PF
    GRAU, GE
    ALLET, B
    VASSALLI, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) : 1280 - 1289
  • [6] GRAFT-VERSUS-HOST DISEASE - NEW DIRECTIONS FOR A PERSISTENT PROBLEM
    VOGELSANG, GB
    HESS, AD
    [J]. BLOOD, 1994, 84 (07) : 2061 - 2067